Navigation Links
New Quality Control Systems for Every Laboratory Application


Betsy Donnelly, MT (ASCP)
Contributing Editor

Quality Control (QC) materials and procedures are key to meeting the needs of doctors and patients by verifying accuracy and precision of analytical methods. Vendors of these systems can be a valuable resource, designing customized QC materials and protocols to help lab managers ensure that analytical error stays within acceptable limits.

Developing suitable QC materials for today's laboratories is a demanding business. Although the ideal QC material must closely resemble the human sample, providing an equivalent matrix without unnecessary and potentially interfering preservatives, it must also be stable for long periods without special storage needs. It must be conveniently packaged and inexpensive. The material should be available with two or more different levels of analyte, to control the assay across the normal and abnormal range. It must contain known concentrations of the analyte, but it should not contain communicable disease agents. For convenience, a single set of QC materials should contain several analytes tested within the same lab. Finally, the vendor should provide a user support program, assisting customers with data analysis to track the performance of their assays.

With the growth of medical technology and the variety of current analytical methods, the days of a single lyophilized control, used throughout the chemistry laboratory, are long gone. Large medical laboratories are divided into separate analytical areas, for example, toxicology, immunology, and STAT labs, each of which provides a different subset of testing and needs specialized QC materials. Each of these materials would, in turn, be inappropriate for a smaller hospital or a POC laboratory.

Modern medical labs also require a variety of quality control materials because of the variety of samples they handle every day. A single assay, for example, may be performed routinely on s
'"/>




Page: 1 2 3

Related medicine technology :

1. Choosing Lab Quality Management Software
2. Optimizing Quality Control Data Management
3. Controlling the Spread of Healthcare Associated Methicillin Resistant Staphylococcus aureus Requires Active Surveillance
4. Tight Glycemic Control in the ICU
5. Diagnosing Diabetes: Immediate HbA1c Results Improve Glycemic Control
6. When Volume Matters, Immunoassay Systems Deliver
7. Genetic Analysis Systems Enter the Clinical Mainstream
8. Immunoassay Systems - Your Laboratory Workhorse
9. Urinalysis Analyzers: Large Capabilities in Every Size Device
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: New Quality Control Systems for Every Laboratory Application
(Date:5/16/2008)...y 16 /- Memory Pharmaceutic...s with several key development,programs at its R&D...mpany,reported new clinical data for MEM 1414, its... CNS activity in humans. In addition, the,Company ...ndidate from its,5-HT6 antagonist program, and sep...
(Date:5/16/2008)... 16 /- BioVex Inc, a biotechnology,co...gy and infectious,disease, announced today that th... Phase II clinical trial of OncoVEX GM-CSF in adva...merican Society of Clinical Oncology,(ASCO) websit...he abstract,which describes the data as of the sub...
(Date:5/16/2008)...ntial Biomarkers -- for Lung Cancer Diagnosis and,...ancer of Unknown Primary ...cer Types With High Sensitivity and, Specificity...f Cancer Results of microRNA Signature to Identif...xceeding 90% and Specificity of 99%, REHOVOT, Isr...
(Date:5/16/2008)...es Statistically Significant Reductions in Selecte...Abstract to be published in 2008 Proceedings of th...inical Oncology, SAN DIEGO, May 16 /PRNewswire-Fi... ANX ) announced today that, in a registrational b... a statistically significant reduction,in general ...
Breaking Medicine Technology:Memory Pharmaceuticals Highlights Progress with Key Programs at its R&D Day 2Memory Pharmaceuticals Highlights Progress with Key Programs at its R&D Day 3Memory Pharmaceuticals Highlights Progress with Key Programs at its R&D Day 4BioVex to Report Phase II Clinical Trial Results of OncoVEX GM-CSF in Metastatic Melanoma at the 2008 American Society of Clinical Oncology Meeting 2BioVex to Report Phase II Clinical Trial Results of OncoVEX GM-CSF in Metastatic Melanoma at the 2008 American Society of Clinical Oncology Meeting 3Rosetta Genomics to Present Multiple Posters at the 44th Annual Meeting of the American Society of Clinical Oncology (ASCO) 2Rosetta Genomics to Present Multiple Posters at the 44th Annual Meeting of the American Society of Clinical Oncology (ASCO) 3Rosetta Genomics to Present Multiple Posters at the 44th Annual Meeting of the American Society of Clinical Oncology (ASCO) 4Rosetta Genomics to Present Multiple Posters at the 44th Annual Meeting of the American Society of Clinical Oncology (ASCO) 5Rosetta Genomics to Present Multiple Posters at the 44th Annual Meeting of the American Society of Clinical Oncology (ASCO) 6ADVENTRX Announces ANX-530 Safety Data From Registrational Bioequivalence Clinical Study 2ADVENTRX Announces ANX-530 Safety Data From Registrational Bioequivalence Clinical Study 3ADVENTRX Announces ANX-530 Safety Data From Registrational Bioequivalence Clinical Study 4ADVENTRX Announces ANX-530 Safety Data From Registrational Bioequivalence Clinical Study 5Kensey Nash Receives FDA 510 28k 29 Clearance for New Safe Cross 28R 29 Vessel Wall Detection Technology 3426 1Kensey Nash Receives FDA 510 28k 29 Clearance for New Safe Cross 28R 29 Vessel Wall Detection Technology 3426 2Kensey Nash Receives FDA 510 28k 29 Clearance for New Safe Cross 28R 29 Vessel Wall Detection Technology 3426 3Kensey Nash Receives FDA 510 28k 29 Clearance for New Safe Cross 28R 29 Vessel Wall Detection Technology 3426 4Kensey Nash Receives FDA 510 28k 29 Clearance for New Safe Cross 28R 29 Vessel Wall Detection Technology 3426 5Inclusion of Six Year Overall Survival Data in the Eloxatin 28R 29 28oxaliplatin injection 29 Prescribing Information Granted FDA Priority Review 1397 1Inclusion of Six Year Overall Survival Data in the Eloxatin 28R 29 28oxaliplatin injection 29 Prescribing Information Granted FDA Priority Review 1397 2Inclusion of Six Year Overall Survival Data in the Eloxatin 28R 29 28oxaliplatin injection 29 Prescribing Information Granted FDA Priority Review 1397 3Warning 3A Expert at UH adds obesity to side effects of lead exposure 12361 1Warning 3A Expert at UH adds obesity to side effects of lead exposure 12361 2Drinking milk may help ease the pressure 2277 1Drinking milk may help ease the pressure 2277 2
...Age People with Diabetes, Hospital,and Professiona..., PITTSBURGH, April 02, 2007 /PRNewswire-FirstCall...) announced today the,release of a new report on t...e with Type 2 diabetes. The inaugural Pittsburgh T...w of patient,demographics, hospital and profession...
...Strong Immune Response, Protection,Against H9N2 In...Newswire-FirstCall/ -- Novavax,Inc.,s virus- like ...esponse and provided protection against the H9N2 s...al data published in the online,edition of the jou...ree animal models, including,the ferret, which is ...
Other Medicine Technology:State of Diabetes in Pittsburgh: Pittsburgh Business Group on,Health Releases Report 2State of Diabetes in Pittsburgh: Pittsburgh Business Group on,Health Releases Report 3State of Diabetes in Pittsburgh: Pittsburgh Business Group on,Health Releases Report 4Novavax Vaccine Provides Robust Immune Response, Pre-Clinical Data,Show 2Novavax Vaccine Provides Robust Immune Response, Pre-Clinical Data,Show 3Novavax Vaccine Provides Robust Immune Response, Pre-Clinical Data,Show 4
(Date:5/16/2008)...plc (LSE: HNT), "the Group",a leading internation...group headquartered in London, released its interi...rformance in the first quarter 2008 (the period,en...low., 15 May 2008, H...ement Statement, Record net new busine...
(Date:5/16/2008)... the lesson of helping others in t..., May 16 /PRNewswire/ -- In the aftermath of the,d...embers of China are,looking for ways to join in th...try, schools are running donation drives and fund-...Ms. Zhang Lijun, the 190-student strong,Nanjing Fu...
(Date:5/16/2008)...007, WASHINGTON, May 16 /PRNewswire-USNewswire/ -...ths, the National Cancer Institute (NCI) invested,...ncer research in 2007,according to updated statis... The two other federal agencies with significant c...trol and Prevention (CDC) and the,Department of De...
(Date:5/16/2008)...rce announced today the,hiring of John Mongeon as ...Mongeon formerly headed up the Government Services...ernment sales and marketing initiatives for,the CI...ions in the IT,industry., Mongeon, a resident of ... to spend more time with his two-year old son. In ...
Breaking Medicine News(10 mins):Health News:Huntsworth plc Releases Interim Statement on First Quarter 2008 2Health News:Huntsworth plc Releases Interim Statement on First Quarter 2008 3Health News:Huntsworth plc Releases Interim Statement on First Quarter 2008 4Health News:Chinese Preschoolers Participate in Fund Drive to Help the Victims of Sichuan Quake 2Health News:Lung Cancer Still Lowest in Federal Funding 2
... apparently of no use in tennis elbow and a wait a...the BMJ says. // Australian researchers tested thi...sured that their problem would be sorted out. A ...osteroid injection and advised to gradually return...
...py (Allergy) Research Center at the Juntendo Unive...dy that dust mites // as well as their droppings h...d leave people exposed to infections. Previous st...o eczema and other allergies, but this study expla...
...oped a vaccine that it says can ward off common al...The vaccine by Cytos Biotechnology has been tested...at found in the TB bug, reported the online editio...thma have doubled in the past 20 years, with the c...
...ous demands for additional staff, the count of con...by less than 1% in three months//. The British Med...ent hardly compensates for the consultant vacancie...t figures published, it is evident that the number...
Other Medicine News:Health News:Steroids Ineffective In Tennis Elbow 2
...scopic CycloPhotocoagulation (ECP) is a surgical a... endoscopy and visualized laser application. The c...wed by the surgeon, from the anterior or posterior...target tissues are easily and accurately identifie...
...scopic CycloPhotocoagulation (ECP) is a surgical a... endoscopy and visualized laser application. The c...wed by the surgeon, from the anterior or posterior...target tissues are easily and accurately identifie...
Centuries of German Craftsmanship have produced the finest surgical instrumentation in the world. Ocutek® now makes them available to you! Only holders of the coveted Meisterbrief certificate, wh
Centuries of German Craftsmanship have produced the finest surgical instrumentation in the world. Ocutek® now makes them available to you! Only holders of the coveted Meisterbrief certificate, wh
Medicine Products: